INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 179S179 trades$43.30M
  3. 03SPSaba Capital Management, L.P.66B / 17S · 11 late83 trades$22.10M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 37S37 trades$1.72M
  8. 08CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10ABAndreas Bechtolsheim0B / 33S33 trades$143.06M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
OM
O'Connor Gavin M.See Remarks
XPOFXponential Fitness, Inc.
Grant or award
A—
137.9K sh
Nov 24, 2025Nov 26, 2025
Page 1747 of 1855
← PrevNext →
traded Nov 24, 2025
+2d
SEC Form 4

Evidence

9
DN
Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$1,060
2,544 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
8,000 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$301
723 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Option exercise
M—
17 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
DM
Duncan Thomas MichaelSVP, Chief Accounting Officer
TNLTravel & Leisure Co.
Tax withholding
F$26K
385 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
HE
Hays Von ESr EVP and Chief Legal Officer
CMACOMERICA INC
Option exercise
M$43K
720 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Weiskircher StevenSVP & Chief Technology Officer
LQDTLIQUIDITY SERVICES INC
Option exercise
M$18K
1,282 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
WS
Weiskircher StevenSVP & Chief Technology Officer
LQDTLIQUIDITY SERVICES INC
Option exercise
M$10K
591 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
WS
Weiskircher StevenSVP & Chief Technology Officer
LQDTLIQUIDITY SERVICES INC
Option exercise
M$15K
1,087 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
ML
Martinez LucindaDirector
TNLTravel & Leisure Co.
Grant or award
A—
738 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Wheeler SimonEVP, Trupanion International
TRUPTRUPANION, INC.
Option exercise
M—
321 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
DP
Duraibabu PrathyushaPRINCIPAL FINANCIAL OFFICER
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$1,060
2,544 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
RN
Richard Stephanie NChief Risk Officer
ALLYAlly Financial Inc.
Tax withholding
F$17K
460 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WB
Willoughby Scott B.SVP, CHIEF LEGAL OFFICER, SECY
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$848
2,035 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
TR
Trout Harry R. IIISee Remarks
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
12.9K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
LR
Luly Jay R.Director, President and CEO
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
310.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
100.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
UJ
Ung JeremyChief Technology Officer
BLBLACKLINE, INC.
Grant or award
A—
1,910 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Weinrauch SteveEVP, North Am & Vet Strategy
TRUPTRUPANION, INC.
Option exercise
M—
354 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Weiskircher StevenSVP & Chief Technology Officer
LQDTLIQUIDITY SERVICES INC
Option exercise
M$16K
946 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Option exercise
M—
27 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Weinrauch SteveEVP, North Am & Vet Strategy
TRUPTRUPANION, INC.
Tax withholding
F$4,561
129 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
AK
Allanson KatherineChief Financial Officer
VHCVirnetX Holding Corp
Grant or award
A—
30.0K sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
WS
Weinrauch SteveEVP, North Am & Vet Strategy
TRUPTRUPANION, INC.
Tax withholding
F$318
9 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
MT
McGrath Austin ThomasVP, CAO, and Controller
ALLYAlly Financial Inc.
Tax withholding
F$1,995
53 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Wheeler SimonEVP, Trupanion International
TRUPTRUPANION, INC.
Option exercise
M—
975 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
GR
Gallagher John RChief Operating Officer
TRUPTRUPANION, INC.
Option exercise
M—
734 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Weinrauch SteveEVP, North Am & Vet Strategy
TRUPTRUPANION, INC.
Option exercise
M—
40 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
HE
Hays Von ESr EVP and Chief Legal Officer
CMACOMERICA INC
Option exercise
M$44K
812 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
HE
Hays Von ESr EVP and Chief Legal Officer
CMACOMERICA INC
Option exercise
M—
720 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
MW
Mulhern Timothy WChief Innovation Officer
TFSLTFS Financial CORP
Grant or award
A—
5,700 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
RA
Rothstein AdamDirector
BZFDBuzzFeed, Inc.
Grant or award
A—
202.7K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
PL
Patterson Kathleen L.Chief HR & Corp Citizenship
ALLYAlly Financial Inc.
Tax withholding
F$18K
469 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
JN
Jain NikunjPrincipal Accounting Officer
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$241
578 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
AB
Ames BrianDirector
SVVSavers Value Village, Inc.
Grant or award
A—
9,090 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Tax withholding
F$318
9 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
HE
Hays Von ESr EVP and Chief Legal Officer
CMACOMERICA INC
Option exercise
M—
1,220 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
GR
Gallagher John RChief Operating Officer
TRUPTRUPANION, INC.
Tax withholding
F$10K
288 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
UJ
Ung JeremyChief Technology Officer
BLBLACKLINE, INC.
Grant or award
A—
1,910 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence